(16721699), I. M., (16721702), O. D., (16721705), R. S., (16721708), J. G., (16721711), B. Y., (16721714), A. D., . . . (16721732), W. S. H. (2025). Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma.
Chicago-čujuhus (17. p.)(16721699), Isha Mondal, et al. Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma. 2025.
MLA-čujuhus (9. p.)(16721699), Isha Mondal, et al. Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma. 2025.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.